StoneRidge PMG Advisors, LLC’s Niagen Bioscience NAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-14,477
Closed -$49K – 158
2026
Q2
$49K Sell
14,477
-36,164
-71% -$147K 0.03% 144
2026
Q1
$223K Hold
50,641
– – 0.16% 94
2025
Q4
$322K Buy
+50,641
New +$352K 0.22% 85

Other funds holding NAGE

StoneRidge PMG Advisors, LLC's NAGE Position: Q3 2026 in Review

StoneRidge PMG Advisors, LLC sold out of Niagen Bioscience (NAGE) in Q3 2026, closing a stake of 14,477 shares — an estimated $49K sold.

StoneRidge PMG Advisors, LLC first reported a position in NAGE in Q4 2025 and held it in 3 quarters. The position peaked at $322K in Q4 2025. 124 funds tracked by Wall St. Rank hold NAGE as of Q3 2026.

  • StoneRidge PMG Advisors, LLC reported no remaining Niagen Bioscience position as of Q3 2026 after selling out during the quarter.
  • StoneRidge PMG Advisors, LLC sold 14,477 Niagen Bioscience shares in Q3 2026, an estimated $49K.
  • StoneRidge PMG Advisors, LLC first reported a position in Niagen Bioscience in Q4 2025 and held it in 3 quarters.
  • StoneRidge PMG Advisors, LLC's Niagen Bioscience position peaked at $322K in Q4 2025.
  • 124 funds tracked by Wall St. Rank held Niagen Bioscience as of Q3 2026.

Based on StoneRidge PMG Advisors, LLC's 13F filing for Q3 2026, filed 4 Nov 2026.